Hong Kong stocks in action: Fosun Pharma (02696.HK) rises more than 7% after earnings, hitting a new high. Internationalization strategy continues to advance, with overseas product profits achieving more than double growth in the first half of the year.

According to the AI Finance APP, Fosun Pharma (02696.HK) rose more than 7% after its performance, reaching a high of 85.95 Hong Kong dollars, a new historical high. As of the time of publication, it has increased by 7.06%, trading at 85.7 Hong Kong dollars, with a turnover of 66.43 million Hong Kong dollars.